{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:16:03Z","timestamp":1790255763747,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1682,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID)","award":["U24-CA76518"],"award-info":[{"award-number":["U24-CA76518"]}]},{"name":"NHLBI and NCI","award":["5U01HL069294"],"award-info":[{"award-number":["5U01HL069294"]}]},{"name":"Health Resources and Services Administration (HRSA\/DHHS)","award":["HHSH234200637015C"],"award-info":[{"award-number":["HHSH234200637015C"]}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"crossref","award":["N00014-06-1-0704"],"award-info":[{"award-number":["N00014-06-1-0704"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"crossref","award":["N00014-08-1-0058"],"award-info":[{"award-number":["N00014-08-1-0058"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AABB; Aetna; American Society for Blood and Marrow Transplantation; Amgen, Inc."}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.bbmt.2010.03.009","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T04:35:13Z","timestamp":1268886913000},"page":"1237-1244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Reduced-Intensity Conditioning Regimens for\u00a0Allogeneic Transplantation in Children with Acute Lymphoblastic Leukemia"],"prefix":"10.1016","volume":"16","author":[{"given":"Michael R.","family":"Verneris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Eapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Duerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.V.","family":"Afanasyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Krance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poh-Lin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.03.009_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.03.009_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bbmt.2005.08.035","article-title":"The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review","volume":"11","author":"Hahn","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib3","first-page":"560","article-title":"Reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation","volume":"5","author":"Alousi","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.bmt.1701672","article-title":"Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation","volume":"23","author":"Elmaagacli","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib6","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1038\/sj.leu.2402712","article-title":"Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease","volume":"16","author":"Arnold","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.03.009_bib7","first-page":"555","article-title":"Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study","volume":"88","author":"Martino","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2010.03.009_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.bmt.1704776","article-title":"Reduced-intensity stem-cell transplantation for adult acute lymphoblastic leukemia: a retrospective study of 33 patients","volume":"35","author":"Hamaki","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/leu.2009.102","article-title":"Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study","volume":"23","author":"Cho","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.03.009_bib10","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1182\/blood-2008-10-184093","article-title":"Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation","volume":"113","author":"Bachanova","year":"2009","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2010.03.009_bib11","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.cco.0000357466.38219.0f","article-title":"Reduced-intensity conditioning for allogeneic stem cell transplantation: 10 years later","volume":"21","author":"Mohty","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib12","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","article-title":"Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome","volume":"19","author":"Michallet","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.1051","article-title":"Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens","volume":"66","author":"Ruiz-Arguelles","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib14","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1182\/blood-2009-01-196303","article-title":"Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313","volume":"114","author":"Pulsipher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.009_bib15","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib16","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1182\/blood.V75.12.2459.2459","article-title":"Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation","volume":"75","author":"Atkinson","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.009_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative incidence functions in competing risks studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2010.03.009_bib18","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.03.009_bib20","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbmt.2008.12.495","article-title":"Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants","volume":"15","author":"Davies","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V77.7.1423.1423","article-title":"Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia","volume":"77","author":"Bacigalupo","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.009_bib22","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1182\/blood.V95.5.1572.005k12_1572_1579","article-title":"Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial","volume":"95","author":"Locatelli","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.03.009_bib23","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/sj.leu.2401581","article-title":"Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children","volume":"13","author":"Bader","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.03.009_bib24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.bmt.1705853","article-title":"Graft-versus-leukemia effect in hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia: significantly lower relapse rate in unrelated transplantations","volume":"40","author":"Gassas","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.03.009_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2141.2008.07260.x","article-title":"Understanding and harnessing the graft-versus-leukaemia effect","volume":"142","author":"Barrett","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2010.03.009_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/sj.bmt.1701064","article-title":"Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia","volume":"21","author":"Passweg","year":"1998","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911000114X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S108387911000114X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:36:26Z","timestamp":1761057386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S108387911000114X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S108387911000114X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced-Intensity Conditioning Regimens for\u00a0Allogeneic Transplantation in Children with Acute Lymphoblastic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}